LVTX
insider transactionsLAVA Therapeutics NV — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-6.9M
0 buy · 6.9M sell
Net value · 365d
-$9.9M
$0 in · $9.9M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
15
0 buy · 6.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Powell Fred M KEY
Chief Financial Officer
$0
124.7K sh
Own -100%
-
Other·D
Powell Fred M KEY
Chief Financial Officer
—
65.0K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
HURLY STEPHEN A KEY
Chief Executive Officer
$0
335.1K sh
Own -100%
-
Other·D
HURLY STEPHEN A KEY
Chief Executive Officer
—
5.0K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Director
—
30.0K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Director
$0
33.4K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Sell·S
Cooperatieve Gilde Healthcare IV U.A.
TenPercentOwner
$1.7M
1.2M sh · $1.47
Own -29%
-
Sell·S
Cooperatieve Gilde Healthcare IV U.A.
TenPercentOwner
$1.0M
690.2K sh · $1.49
Own -14%
-
Sell·S
Cooperatieve Gilde Healthcare IV U.A.
TenPercentOwner
$343.3K
227.3K sh · $1.51
Own -4%
-
Sell·S
Cooperatieve Gilde Healthcare IV U.A.
TenPercentOwner
$73.4K
47.7K sh · $1.54
Own -1%
-
Sell·S
TenPercentOwner
$77.3K
49.9K sh · $1.55
Own -1%
-
Sell·S
TenPercentOwner
$75.1K
48.2K sh · $1.56
Own -1%
-
Sell·S
TenPercentOwner
$45.5K
29.0K sh · $1.57
Own -1%
-
Sell·S
TenPercentOwner
$746.0K
532.9K sh · $1.40
Own -100%
-
Sell·S
TenPercentOwner
$3.3M
2.4M sh · $1.40
Own -100%
-
Sell·S
TenPercentOwner
$329.5K
228.8K sh · $1.44
Own -30%
-
Sell·S
TenPercentOwner
$527.2K
366.1K sh · $1.44
Own -13%
-
Sell·S
TenPercentOwner
$337.8K
226.7K sh · $1.49
Own -23%
-
Sell·S
TenPercentOwner
$540.6K
362.8K sh · $1.49
Own -12%
-
Sell·S
TenPercentOwner
$294.2K
192.3K sh · $1.53
Own -16%
-
Sell·S
TenPercentOwner
$470.8K
307.7K sh · $1.53
Own -9%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2025 | Backstrom Jay T. | Other D | 33.4K | $0 |
| Nov 13, 2025 | Powell Fred M KEY | Other D | 124.7K | $0 |
| Nov 13, 2025 | Powell Fred M KEY | Other D | 65.0K | — |
| Nov 13, 2025 | Noble James | Other D | 33.4K | $0 |
| Nov 13, 2025 | HURLY STEPHEN A KEY | Other D | 335.1K | $0 |
| Nov 13, 2025 | HURLY STEPHEN A KEY | Other D | 5.0K | — |
| Nov 13, 2025 | Dhingra Kapil | Other D | 33.4K | $0 |
| Nov 13, 2025 | Dhingra Kapil | Other D | 30.0K | — |
| Nov 13, 2025 | Wadlinger Mary E. | Other D | 33.4K | $0 |
| Nov 13, 2025 | Oliger Christy J. | Other D | 33.4K | $0 |
| Nov 13, 2025 | Kiener Peter A | Other D | 33.4K | $0 |
| Nov 13, 2025 | WILSON KAREN J | Other D | 33.4K | $0 |
| Nov 13, 2025 | WILSON KAREN J | Other D | 10.0K | — |
| Oct 17, 2025 | Cooperatieve Gilde Healthcare IV U.A. | Sell S | 1.2M | $1.7M |
| Oct 16, 2025 | Cooperatieve Gilde Healthcare IV U.A. | Sell S | 690.2K | $1.0M |
| Oct 14, 2025 | Cooperatieve Gilde Healthcare IV U.A. | Sell S | 227.3K | $343.3K |
| Oct 13, 2025 | Cooperatieve Gilde Healthcare IV U.A. | Sell S | 47.7K | $73.4K |
| Oct 10, 2025 | Gilde Healthcare Holding B.V. | Sell S | 49.9K | $77.3K |
| Oct 9, 2025 | Gilde Healthcare Holding B.V. | Sell S | 48.2K | $75.1K |
| Oct 8, 2025 | Gilde Healthcare Holding B.V. | Sell S | 29.0K | $45.5K |
| Sep 19, 2025 | Versant Vantage I, L.P. | Sell S | 532.9K | $746.0K |
| Sep 19, 2025 | Versant Vantage I, L.P. | Sell S | 2.4M | $3.3M |
| Sep 18, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 228.8K | $329.5K |
| Sep 18, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 366.1K | $527.2K |
| Sep 17, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 226.7K | $337.8K |
| Sep 17, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 362.8K | $540.6K |
| Sep 16, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 192.3K | $294.2K |
| Sep 16, 2025 | Versant Vantage I GP-GP, LLC | Sell S | 307.7K | $470.8K |
About LVTX insider trading
This page tracks insider transactions for LAVA Therapeutics NV (LVTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.